Correlation Between AN2 Therapeutics and Exicure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Exicure, you can compare the effects of market volatilities on AN2 Therapeutics and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Exicure.

Diversification Opportunities for AN2 Therapeutics and Exicure

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between AN2 and Exicure is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Exicure go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Exicure

Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Exicure. But the stock apears to be less risky and, when comparing its historical volatility, AN2 Therapeutics is 1.86 times less risky than Exicure. The stock trades about -0.01 of its potential returns per unit of risk. The Exicure is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  620.00  in Exicure on September 12, 2024 and sell it today you would earn a total of  995.00  from holding Exicure or generate 160.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

AN2 Therapeutics  vs.  Exicure

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Exicure 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.

AN2 Therapeutics and Exicure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Exicure

The main advantage of trading using opposite AN2 Therapeutics and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.
The idea behind AN2 Therapeutics and Exicure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine